Skip to main content

Get Health Care
About
Giving
Find Faculty
Library
RUSH U Portal
I am a...
Select from the list below to customize your experience: Select a new category

I am a:

Education
Looking to take the next step in your career? RUSH University offers a wide range of education and training options, including nationally ranked academic programs.

Find a Program
- Colleges
- Quick Links
Admissions
Student Life
Experience what life is like at RUSH University, and discover what our supportive learning community has to offer.

Learn More About Student Life
- About the RUSH Experience
- Quick Links
Research
RUSH researchers are leading efforts to cure disease and promote health equity — in Chicago and around the world.

Learn More About Research
- About Our Research
- Quick Links

Get Health Care
About
Giving
Find Faculty
Library
RUSH U Portal
I am a...
Select from the list below to customize your experience: Select a new category

I am a:

Search RUSH University

Elizabeth M. Berry-Kravis, MD, PhD

Breadcrumb

Home
Elizabeth M. Berry-Kravis, MD, PhD

Home

Professor, Department of Pediatrics

Rush Medical College

Professor, Department of Pediatrics

Co-Director, Molecular Diagnostics Section of the Genetic Laboratory

Contact Information

Address: 1725 W. Harrison St., Suite 710
Chicago, IL 60612
Phone:
(312) 942-4036
Fax:
(312) 942-4168

Links

Print this Page

Off

MD, University of Chicago Pritzker School of Medicine
- NIH RO1HD071987, Decisional Capacity and Informed Consent in Fragile X Syndrome, Consultant
- NIH NCT01525901/U54 NS092090-01, Developmental Synaptopathies Associated with TSC, PTEN and SHANK3 Mutations, Co-PI
- NIH 1R01HD076189-01A1, A Cognitive Test Battery for Intellectual Disabilities, Co-Investigator
- NIH 1RO1HD074346-01A1, Expressive Language Sampling as an Outcome Measure, Co-Investigator
- NIH RO1 MH091131, A Family Genetic Study of Autism and Fragile X Syndrome, Co- Investigator
- CDC 1U01 DD001186-01, Using Longitudinal Data to Characterize the Natural History of Fragile X Syndrome: Component C, Principal Investigator
- CDC 1 U01 DD001189-01, Using Longitudinal Data to Characterize the Natural History of Fragile X Syndrome: Component A, Consultant
- NCT02534844, A Phase 2b/3 Prospective, Randomized, Double-Blind, Sham-Controlled 3-Part Trial of 2-hydroxypropyl-_-cyclodextrin (VTS-270) in Subjects With Neurologic Manifestations of Niemann-Pick Type C1 (NPC1) Disease, Principal Investigator
- NCT01911455, Acamprosate in Fragile X Syndrome", Co-PI
- Neurodevelopmental Disorders Research Registry, Principal Investigator
- Neurological Phenotype in FMR1 Premutation Carriers, Principal Investigator
- Intrathecal 2-Hydroxypropyl-_-cyclodextrin for Neurological Decline in Patients with Niemann-Pick Disease Type C1, Principal Investigator
- Electrophysiological Biomarkers of Phelan-McDermid Syndrome, Principal Investigator

Main Section
- Colleges
- For Professionals
- For Students
- Resources
(312) 942-7100

RUSH University
600 S. Paulina St.
Chicago, Illinois 60612

Contact Us

Accessibility, Privacy & Harassment Policies

© 2024 RUSH University